ATE424833T1 - Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure - Google Patents

Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure

Info

Publication number
ATE424833T1
ATE424833T1 AT02782023T AT02782023T ATE424833T1 AT E424833 T1 ATE424833 T1 AT E424833T1 AT 02782023 T AT02782023 T AT 02782023T AT 02782023 T AT02782023 T AT 02782023T AT E424833 T1 ATE424833 T1 AT E424833T1
Authority
AT
Austria
Prior art keywords
reptiles
birds
mammals
mannuronic acid
linked beta
Prior art date
Application number
AT02782023T
Other languages
English (en)
Inventor
Olav Gaserod
Arne Dessen
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE424833T1 publication Critical patent/ATE424833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
AT02782023T 2001-11-30 2002-11-29 Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure ATE424833T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20015875A NO326145B1 (no) 2001-11-30 2001-11-30 Fremgangsmate for a stimulere vektokning hos pattedyr, fugler og krypdyr.

Publications (1)

Publication Number Publication Date
ATE424833T1 true ATE424833T1 (de) 2009-03-15

Family

ID=19913092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02782023T ATE424833T1 (de) 2001-11-30 2002-11-29 Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure

Country Status (9)

Country Link
US (1) US7893038B2 (de)
EP (1) EP1461050B1 (de)
CN (2) CN102210700A (de)
AT (1) ATE424833T1 (de)
AU (1) AU2002348539A1 (de)
DE (1) DE60231550D1 (de)
DK (1) DK1461050T3 (de)
NO (1) NO326145B1 (de)
WO (1) WO2003045402A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO329913B1 (no) * 2004-09-13 2011-01-24 Torfinn Johnsen Pulverblanding for dannelse av vann- og næringsmiddelstabiliserende membran
RU2527894C2 (ru) 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
RU2582938C2 (ru) 2009-06-03 2016-04-27 АльгиФарма АС Альгинатные олигомеры для применения в преодолении множественной лекарственной устойчивости у бактерий
WO2012138885A1 (en) * 2011-04-05 2012-10-11 Knocean Sciences, Inc Macrocystis pyrifera derived health and wellness products and methods of using the same
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
US9918411B2 (en) * 2012-12-20 2018-03-13 Rackspace Us, Inc. Flap-based forced air cooling of datacenter equipment
GB201415381D0 (en) 2014-08-29 2014-10-15 Algipharma As Inhalable powder formulations of alginate oligomers
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
WO2026008878A1 (en) 2024-07-04 2026-01-08 Algipharma As Antimycotic polyene-alginate oligomer conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011205A1 (en) 1990-01-23 1991-08-08 Trancel Corporation Mannuronic acid containing alginate wound healing composition and method
US5169840A (en) * 1991-03-27 1992-12-08 Nobipols Forskningsstiftelse Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
GB9221163D0 (en) 1992-10-08 1992-11-25 Nobipol And Protan Biopolymer Dna compounds
NO305033B1 (no) * 1997-05-09 1999-03-22 Algipharma As Fremgangsmate for fremstilling av uronsyreblokker fra alginat
US6338856B1 (en) * 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품

Also Published As

Publication number Publication date
WO2003045402A1 (en) 2003-06-05
DE60231550D1 (de) 2009-04-23
US20050080036A1 (en) 2005-04-14
NO20015875L (no) 2003-06-02
CN1599615A (zh) 2005-03-23
AU2002348539A1 (en) 2003-06-10
CN102210700A (zh) 2011-10-12
NO326145B1 (no) 2008-10-06
US7893038B2 (en) 2011-02-22
EP1461050B1 (de) 2009-03-11
NO20015875D0 (no) 2001-11-30
EP1461050A1 (de) 2004-09-29
DK1461050T3 (da) 2009-06-08

Similar Documents

Publication Publication Date Title
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
FR2825925B1 (fr) Procede de preparation d'un principe actif a partir de riz, principe actif obtenu et compositions adaptees
MXPA05010682A (es) Compuestos novedosos.
DE60231550D1 (de) Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d-mannuronsäure
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
AR029590A1 (es) Antibacterianos
WO2005053421A3 (en) Palatability enhanced composition and method for animal consumption
ATE343605T1 (de) Zusammensetzungen zur herstellung von aminoplasterzeugnissen
BR0311386A (pt) Furancarboxamidas
DE60006825D1 (de) Serotonerge benzofurane
WO2003045272A3 (en) ORAL IMMUNOSTIMULATION OF MAMMALS, BIRDS, FISH AND REPTILES FROM (1-4) LINKED ß-D-MANNURONIC ACID
PL1831239T3 (pl) Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
MXPA06000336A (es) Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen.
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
PL366988A1 (en) Gelling sugar and method for producing the same
ID27440A (id) Proses untuk menyiapkan penengah-penengah
NO20021727L (no) Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
DE60023402D1 (de) Herstellung von 3-amino-2-chlor-4-methylpyridin aus aceton und ethylcyanoacetat
ATE242763T1 (de) Methoximinophenylessigsäureamide
ATE233783T1 (de) Verfahren zur behandlung organischer substanzen
NO20062246L (no) Oralt immunstimulerende materiale omfattende (1-4)- bundet beta-D-mannuronsyre, samt fremgangsmate for a stimulere immunsystemet av pattedyr, fugler og krypdyr med et preparat som inneholder materialet
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties